ResMed
ResMed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19. Resmed also provides software to out-of-hospital care agencies to streamline transitions of care into and between these care settings for seniors and their care providers.
Recent news mentioning ResMed
- — Atresmedia repartirá un dividendo de 187 millones tras la desinversión en Fever
- — ResMed Targets 12%-14% EPS Growth as GLP-1 Patients Lift Sleep Therapy Demand
- — ResMed Inc. (RMD)’s Sleep Apnea Leadership Supports Growth Despite Rising Competitive Pressures
- — Sleep Device Maker ResMed Gets an Upgrade. Analysts See a Lot to Like.
- — This Analyst Just Upgraded ResMed Stock. Here's Why.
- — Atresmedia vende el 5% que mantenía en Fever por 227 millones
- — ResMed Stock: Is RMD Underperforming the Healthcare Sector?
- — INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ResMed Inc. - RMD
- — ResMed Stock: Analyst Estimates & Ratings
- — La CNMC exige a Atresmedia separar Clear Channel del resto de su negocio publicitario
- — ResMed’s (RMD) Sleep Business Booms Even As One Product Stumbles
- — ResMed (RMD) Q4 2026 Earnings Call Transcript